Peer-reviewedCC BY-NC-NDAlzheimer's & dementia : the journal of the Alzheimer's Association
Dementia with Lewy bodies and amyloid pathology: Eligible for anti‐amyloid treatment or not?
- 1Amsterdam UMC Vrije Universiteit Amsterdam
- 2Stavanger University Hospital
Related
- Estimating the eligible population for amyloid-targeting monoclonal antibody therapy in memory clinics: Application to lecanemab in France.
- Generalizing Amyloid β Pathology from Postmortem Human Brains with Vision Foundation Models for Lesion Quantification
- Integrative Genetic and Transcriptomic Analysis Reveals Candidate Molecular Differences Among Dementia with Lewy Bodies, Alzheimer’s Disease, and Parkinson’s Disease Dementia
- Fluctuations correlates in advanced dementia with Lewy bodies: A longitudinal study.
- Targeting Pro-Inflammatory Interleukin-1 Beta Signaling to Modulate Neuroinflammatory Processes Associated with Cognitive Decline in Dementia with Lewy Bodies
BibTeX
@article{exalto2026dementia,
title = {{Dementia with Lewy bodies and amyloid pathology: Eligible for anti‐amyloid treatment or not?}},
author = {Lieza G Exalto and Juliette L van Alphen and Frederik Barkhof and Charlotte Teunissen and Everard G. B Vijverberg and Dag Aarsland and Afina W Lemstra},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13656199},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Dementia with Lewy bodies and amyloid pathology: Eligible for anti‐amyloid treatment or not?
AU - Lieza G Exalto
AU - Juliette L van Alphen
AU - Frederik Barkhof
AU - Charlotte Teunissen
AU - Everard G. B Vijverberg
AU - Dag Aarsland
AU - Afina W Lemstra
PY - 2026
DA - 2026/10/01
JO - Alzheimer's & dementia : the journal of the Alzheimer's Association
UR - https://europepmc.org/article/PMC/PMC13656199
SN - 1552-5260
SN - 1552-5279
ER -